Diagnostic utility of CD4%:CD8low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats

Veterinary Microbiology

Volumn 170, Issue 3-4, 2014, Pages 197-205

  Litster, Annette ^a   Lin, Jui Ming ^b   Nichols, Jamieson ^a   Weng, Hsin Yi ^a  

^a PURDUE UNIVERSITY   (United States)

^b IDEXX LABORATORIES   (United States)

Author keywords

Cat; CD4; Diagnosis; FIV Vaccine; Retrovirus

Indexed keywords

FELINE IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ARTICLE; CAT; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; FELINE IMMUNODEFICIENCY VIRUS INFECTION; FEMALE; GINGIVA DISEASE; IMMUNOSTIMULATION; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE; VIRUS INFECTION;

FELINE IMMUNODEFICIENCY VIRUS;

CAT; CD4; CD8(LOW); DIAGNOSIS; FIV VACCINE; RETROVIRUS;

ANIMALS; CATS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; MALE; VACCINATION;

EID: 84898482821     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.01.014     Document Type: Article

References (39)

1. Ammersbach M., Little S., Bienzle D. Preliminary evaluation of a quantitative polymerase chain reaction assay for diagnosis of feline immunodeficiency virus infection. J. Fel. Med. Surg. 2013, 15:725-729.
2. Anderson P.R., Tyrell P. Feline immunodeficiency virus diagnosis after vaccination. Anim. Health Res. Rev. 2004, 5:327-330.
3. Barlough J.E., Ackley C.D., George J.W., Levy N., Acevedo R., Moore P.F., Rideout B.A., Cooper M.D., Pedersen N.C. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquir. Immune Defic. Syndr. 1991, 4:219-227.
4. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 1995, 8:87-112.
5. Bienzle D., Reggeti F., Wen X., Little S., Hobson J., Kruth S. The variability of serological and molecular diagnosis of feline immunodeficiency virus infection. Can. Vet. J. 2004, 45:753-757.
6. Bortnick S.J., Orandle M.S., Papadi G.P., Johnson C.M. Lymphocyte subsets in neonatal and juvenile cats: comparison of blood and lymphoid tissues. Lab. Anim. Sci. 1999, 49:395-400.
7. + cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 β chain. J. Infect. Dis. 1998, 178:968-977.
8. Bucci J.G., English R.V., Jordan H.L., Childers T.A., Tompkins M.B., Tompkins W.A. Mucosally transmitted feline immunodeficiency virus induces a CD8 antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 1998, 177:18-25.
9. Burkhard M.J., Dean G.A. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr. HIV Res. 2003, 1:15-29.
10. Campbell D.J., Rawlings J.M., Koelsch S., Wallace J., Strain J.J., Hannigan B.M. Age-related differences in parameters of feline immune status. Vet. Immunol. Immunopathol. 2004, 100:73-80.
11. Crawford P.C., Levy J.K. New challenges for the diagnosis of feline immunodeficiency virus infection. Vet. Clin. North Am. Small Anim. Pract. 2007, 37:335-350.
12. Crawford P.C., Slater M.R., Levy J.K. Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats. J. Am. Vet. Med. Assoc. 2005, 226:1503-1507.
13. Dunham S.P., Bruce J., Mackay S., Golder M., Jarrett O., Neil J.C. Limited efficacy of an inactivated feline immunodeficiency virus vaccine. Vet. Rec. 2006, 158:561-562.
14. Gebhard D.H., Dow J.L., Childers T.A., Alvelo J.I., Tompkins M.B., Tompkins W.A. Progressive expansion of an l-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 1999, 180:1503-1513.
15. Greiner M., Gardner I.A. Application of diagnostic tests in veterinary epidemiologic studies. Prev. Vet. Med. 2000, 45:43-59.
16. Hoffmann-Fezer G., Thum J., Ackley C., Herbold M., Mysliwietz J., Thefeld S., Hartmann K., Kraft W. Decline in CD4+cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol. 1992, 66:1484-1488.
17. Hofmann-Lehmann R., Holznagel E., Aubertb A., Ossent P., Reinacher M., Lutz H. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection. Vet. Immunol. Immunopathol. 1995, 46:127-137.
18. Hosie M.J., Addie D., Belák S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Truyen U., Horzinek M.C. Feline immunodeficiency, ABCD guidelines on prevention and management. J. Feline Med. Surg. 2009, 11:575-584.
19. Huang C., Conlee D., Loop J., Champ D., Gill M., Chu H.J. Efficacy and safety of a feline immunodeficiency virus vaccine. Anim. Health Res. Rev. 2004, 5:295-300.
20. Joshi A., Vahlenkamp T.W., Garg H., Tompkins W.A., Tompkins M.B. Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation. Virology 2004, 321:307-322.
21. Kusuhara H., Hohdatsu T., Okumura M., Sato K., Suzuki Y., Motokawa K., Gemma T., Watanabe R., Huang C., Arai S., Koyama H. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet. Microbiol. 2005, 108:155-165.
22. Lecollinet S., Richardson J. Vaccination against the feline immunodeficiency virus: the road not taken. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31:167-190.
23. Lehmann R., von Beust B., Niederer E., Condrau M.A., Fierz W., Aubert A., Ackley C.D., Cooper M.D., Tompkins M.B., Lutz H. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol 1992, 35:199-214.
24. Levy J.K., Crawford P.C., Slater M.R. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats. J. Am. Vet. Med. Assoc. 2004, 225:1558-1561.
25. Levy J., Crawford C., Hartmann K., Hofmann-Lehmann R., Little S., Sundahl E., Thayer V. American Association of Feline Practitioners' feline retrovirus management guidelines. J. Feline Med. Surg. 2008, 10:300-316.
26. Levy J.K., Crawford P.C., Kusuhara H., Motokawa K., Gemma T., Watanabe R., Arai S., Bienzle D., Hohdatsu T. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats. J. Vet. Intern. Med. 2008, 22:330-334.
27. Levy J.K., Scott H.M., Lachtara J.L., Crawford P.C. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J. Am. Vet. Med. Assoc. 2006, 228:371-376.
28. Lin J.M., Litster A. Fluorescence flow cytometry methodology to exclude platelet aggregate interference when measuring feline CD4 and CD8 lymphocyte counts. Vet. J. 2013, 198:275-278.
29. Litster, A., Leutenegger, C., Estrada, M., Nichols, J., Hosie, M., Beczkowski, P., 2012. Diagnostic accuracy of a commercially available PCR test to detect feline immunodeficiency virus antigen. Proceedings of the 2nd Biennial Symposium of the International Society for Companion Animal Infectious Diseases, San Francisco, CA, Abstract #04 (abstract).
30. Morton J.M., McCoy R.J., Kann R.K., Gardner I.A., Meers J. Validation of real-time polymerase chain reaction tests for diagnosing feline immunodeficiency virus infection in domestic cats using Bayesian latent class models. Prev. Vet. Med. 2012, 104:136-148.
31. Murphy B., Vapniarsky N., Hillman C., Castillo D., McDonnel S., Moore P., Luciw P.A., Sparger E.E. FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection. Retrovirology 2012, 9:12-17.
32. Pu R., Coleman J., Coisman J., Sato E., Tanabe T., Arai M., Yamamoto J.K. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate. J. Feline Med. Surg. 2005, 7:65-70.
33. Reggeti F., Bienzle D. Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol. 2004, 85:1843-1852.
34. Sellon R.K., Levy J.K., Jordan H.L., Gebhard D.H., Tompkins M.B., Tompkins W.A. Changes in lymphocyte subsets with age in perinatal cats: late gestation through eight weeks. Vet. Immunol. Immunopathol. 1996, 53:105-113.
35. Shimojima M., Takayuki M., Kohmoto M., Ikeda Y., Nishimura Y., Maeda K., Tohya Y., Mikami T. Expansion of CD8α+β- cells in cats infected with feline immunodeficiency virus. J. Gen. Virol. 1998, 79:91-94.
36. Tompkins M.B., Nelson P.D., English R.V., Novotney C. Early events in the immunopathogenesis of feline retrovirus infections. J. Am. Vet. Med. Assoc. 1991, 199:1311-1315.
37. Wang C., Johnson C.M., Ahluwalia S.K., Chowdhury E., Li Y., Gao D., Poudel A., Rahman K.S., Kaltenboeck B. Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats. J. Clin. Microbiol. 2010, 48:1667-1672.
38. Weaver E.A. A detailed phylogenetic analysis of FIV in the United States. PLoS ONE 2010, 5:e12004.
39. + lymphocyte subset. Immunology 1993, 78:1-6.